About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Procedure number
- PSUSA/00001493/202303
- Regulatory outcome
- Variation
Documents
Furosemide-spironolactone : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00001493/202303
English (EN) (93.51 KB - PDF)
български (BG) (219.47 KB - PDF)
español (ES) (185.4 KB - PDF)
čeština (CS) (132.45 KB - PDF)
dansk (DA) (156.67 KB - PDF)
Deutsch (DE) (146.77 KB - PDF)
eesti keel (ET) (43.81 KB - PDF)
ελληνικά (EL) (112.92 KB - PDF)
français (FR) (145.39 KB - PDF)
hrvatski (HR) (162.37 KB - PDF)
íslenska (IS) (152.35 KB - PDF)
italiano (IT) (170.94 KB - PDF)
latviešu valoda (LV) (108.85 KB - PDF)
lietuvių kalba (LT) (110.47 KB - PDF)
magyar (HU) (146.65 KB - PDF)
Malti (MT) (182.78 KB - PDF)
Nederlands (NL) (83.86 KB - PDF)
norsk (NO) (83 KB - PDF)
polski (PL) (78.75 KB - PDF)
português (PT) (155.68 KB - PDF)
română (RO) (216.83 KB - PDF)
slovenčina (SK) (85 KB - PDF)
slovenščina (SL) (78.79 KB - PDF)
Suomi (FI) (91.63 KB - PDF)
svenska (SV) (155.79 KB - PDF)
Furosemide-spironolactone : List of nationally authorised medicinal products - PSUSA/00001493/202303
English (EN) (179.78 KB - PDF)